Ultra ‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: Grit Andersen MD , Gr égory Meiffren PhD , Daniela Lamers PhD , J. Hans DeVries MD , Aymeric Ranson MSc , Cyril Seroussi MSc , Bertrand Alluis PhD , Martin Gaudier PhD , Olivier Soula PhD , Tim Heise MD Source Type: research